Mathai Mammen leaves position as JnJ Executive Vice President, Pharmaceuticals, RnD Ruchika Sharma12 Aug 2022 3:00 PM ISTNew Brunswick: Johnson & Johnson has announced that Mathai Mammen, M.D., Ph.D., has decided to leave his position as Executive Vice...
Janssen gets USFDA nod for psoriatic arthritis treatment STELARA for pediatric patients Ruchika Sharma4 Aug 2022 11:46 AM ISTSTELARA is administered as a subcutaneous injection dosed four times per year after two starter doses for the treatment of pediatric patients six...
Coronavirus: India supplies non-JnJ vaccine under Quad umbrella Ruchika Sharma21 May 2022 10:00 AM ISTBagchi did not give numbers, but Indian foreign ministry data shows that India last month sent 200,000 doses of Covovax, a version of the Novavax...
Blood clot risk - USFDA limits use of JnJ COVID vaccine Ruchika Sharma6 May 2022 12:54 PM ISTThe vaccine maker said it has updated the U.S. COVID-19 vaccine fact sheet to warn about the risk of thrombosis with thrombocytopenia syndrome (TTS),...
Stop sale of counterfeit HIV drugs: J&J files plea against drug distributors, pharmacies Roshni Dhar29 April 2022 6:30 PM ISTJohnson & Johnson has filed a lawsuit against drug distributors and a pharmacy seeking to stop the sale of counterfeit versions of its HIV drugs,...
Health Bulletin 29/April/2022 Roshni Dhar29 April 2022 5:07 PM ISTHere are the top health stories for today:NMC officials facing CBI probe on allegations of giving approvals to medical colleges for cash: ReportThe...
Stop sale of counterfeit HIV drugs: JnJ files plea against drug distributors, pharmacies Ruchika Sharma28 April 2022 4:24 PM ISTJnJ said counterfeit bottles sometimes contained a different HIV drug than what was on the label, and in one case contained the powerful antipsychotic...
JnJ suspends sales forecast for COVID vaccine Ruchika Sharma20 April 2022 12:09 PM ISTJnJ said it now expects full-year adjusted profit forecast to be between $10.15 and $10.35 per share, lower than the prior forecast of $ 10.40 to $...
JnJ joins hands with Midatech Pharma for injectables MD Bureau11 March 2022 12:30 PM ISTFollowing the initial programme (MTX213), the collaboration has been extended to include another large molecule to the research performed by Midatech...
J&J unit proposes independent exam if it remains in bankruptcy Ruchika Sharma20 Feb 2022 9:00 AM ISTNew Delhi: A Johnson & Johnson subsidiary proposed on Friday that it would submit to an independent examination of the corporate...
Medical devices, prescription drugs boost JnJ earning in Q4 Ruchika Sharma27 Jan 2022 9:00 AM ISTWashington: Growing prescription drug and medical device sales nudged Johnson & Johnson past fourth-quarter earnings expectations, and the...
Sinovac CoronaVac shot gets strong boost from Pfizer, AstraZeneca, JnJ COVID doses, claims study Ruchika Sharma26 Jan 2022 10:00 AM ISTNew Delhi: A third booster dose of a COVID-19 vaccine made by AstraZeneca, Pfizer-BioNTech or Johnson & Johnson increases antibody levels...
